Ecolab (ECL) Target Trimmed at Citi Amid Shifting Views on Chemicals

By Vardah Gill | December 30, 2025, 3:43 PM

Ecolab Inc. (NYSE:ECL) is included among the 14 Best Dividend Aristocrats to Invest in Heading into 2026.

Ecolab (ECL) Target Trimmed at Citi Amid Shifting Views on Chemicals

On December 18, Citi analyst Patrick Cunningham lowered the price target on Ecolab Inc. (NYSE:ECL) to $315 from $323 and maintained a Buy rating. The update followed revisions to estimates and targets across the chemicals group as part of Citi’s 2026 outlook. Citi said it is turning more cautious on polyethylene producers. At the same time, the firm is more constructive on lithium fundamentals heading into next year.

In other news, on December 16, Ecolab Inc. (NYSE:ECL) closed its previously announced acquisition of Ovivo’s electronics business. The unit is a fast-growing global provider of ultrapure water technologies used in semiconductor manufacturing. The deal expands Ecolab’s reach across the artificial intelligence value chain. That includes everything from chip production to data centers.

Management said the transaction more than doubles the size of its global high-tech growth engine and positions the company as a clear leader in these markets. By combining Ovivo Electronics’ ultrapure water systems with Ecolab’s global water, digital, and service capabilities, the company plans to deliver critical circular water management solutions. The focus is on reducing water use in the water-intensive semiconductor industry.

Ecolab Inc. (NYSE:ECL) is a global sustainability leader that provides water, hygiene, and infection prevention solutions and services aimed at protecting people and essential natural resources.

While we acknowledge the potential of ECL as an investment, we believe certain AI stocks offer greater upside potential and carry less downside risk. If you’re looking for an extremely undervalued AI stock that also stands to benefit significantly from Trump-era tariffs and the onshoring trend, see our free report on the best short-term AI stock.

READ NEXT: 14 Best Pharma Dividend Stocks to Buy in 2026 and 15 Global Dividend Stocks to Diversify Your Portfolio.

Disclosure: None.

Mentioned In This Article

Latest News